| ［1］ |
Cranwell WC, Lai VW, Photiou L, et al. Treatment of alopecia areata: an australian expert consensus statement［J］. Australas J Dermatol, 2019,60（2）:163⁃170. doi: 10.1111/ajd.12941.
|
| ［2］ |
Rossi A, Muscianese M, Piraccini BM, et al. Italian guidelines in diagnosis and treatment of alopecia areata［J］. G Ital Dermatol Venereol, 2019,154（6）:609⁃623. doi: 10.23736/S0392⁃0488.19. 06458⁃7.
|
| ［3］ |
中华医学会皮肤性病学分会毛发学组. 中国斑秃诊疗指南（2019）［J］. 临床皮肤科杂志, 2020,49（2）:69⁃72. doi: 10. 16761/j.cnki.1000⁃4963.2020.02.002.
|
| ［4］ |
Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts （ACE） study: results of an international expert opinion on treatments for alopecia areata［J］. J Am Acad Dermatol, 2020,83（1）:123⁃130. doi: 10.1016/j.jaad.2020.03.004.
|
| ［5］ |
Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts （ACE） study part II: results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata［J］. J Am Acad Dermatol, 2021,84（6）:1594⁃1601. doi: 10.1016/j.jaad.2020.09.028.
|
| ［6］ |
Lee HH, Gwillim E, Patel KR, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2020,82（3）:675⁃682. doi: 10.1016/j.jaad.2019.08.032.
|
| ［7］ |
Wang S, Ratnaparkhi R, Piliang M, et al. Role of family history in patchy alopecia areata［J］. Dermatol Online J, 2018,24（10）:13030/qt0n19r7ps.
|
| ［8］ |
Shin JM, Kim KH, Kim SM, et al. Exome sequencing reveals novel candidate gene variants associated with clinical characteristics in alopecia areata patients［J］. J Dermatol Sci, 2020,99（3）:216⁃220. doi: 10.1016/j.jdermsci.2020.08.003.
|
| ［9］ |
Schepis C, Siragusa M, Happle R. Psoriasis and alopecia areata in a Down syndrome patient: a Renbök phenomenon［J］. Eur J Dermatol, 2017,27（3）:300⁃301. doi: 10.1684/ejd.2017.2977.
|
| ［10］ |
Anzai A, Wang E, Lee EY, et al. Pathomechanisms of immune⁃mediated alopecia［J］. Int Immunol, 2019,31（7）:439⁃447. doi: 10.1093/intimm/dxz039.
|
| ［11］ |
Okhovat JP, Marks DH, Manatis⁃Lornell A, et al. Association between alopecia areata, anxiety, and depression: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2019,S0190⁃9622（19）30890⁃4. doi: 10.1016/j.jaad.2019.05.086.
|
| ［12］ |
Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines⁃⁃Part II. National Alopecia Areata Foundation［J］. J Am Acad Dermatol, 2004,51（3）:440⁃447. doi: 10.1016/j.jaad.2003.09.032.
|
| ［13］ |
Lee H, Choe SJ, Lee WS. Method for describing patterns and distributions of alopecia areata which may be helpful for patient characterization and predicting prognosis［J］. J Dermatol, 2019,46（8）:739⁃740. doi: 10.1111/1346⁃8138.14989.
|
| ［14］ |
Wyrwich KW, Kitchen H, Knight S, et al. Development of Clinician⁃Reported Outcome （ClinRO） and Patient⁃Reported Outcome （PRO） measures for eyebrow, eyelash and nail assessment in alopecia areata［J］. Am J Clin Dermatol, 2020,21（5）:725⁃732. doi: 10.1007/s40257⁃020⁃00545⁃9.
|
| ［15］ |
Chen CH, Wang KH, Lin HC, et al. Follow⁃up study on the relationship between alopecia areata and risk of autoimmune diseases［J］. J Dermatol, 2016,43（2）:228⁃229. doi: 10.1111/1346⁃8138.13165.
|
| ［16］ |
Nasimi M, Abedini R, Ghandi N, et al. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: a large retrospective study of 757 patients［J］. Dermatol Ther, 2020,33（6）:e13808. doi: 10.1111/dth.13808.
|
| ［17］ |
Pourang A, Mesinkovska NA. New and emerging therapies for alopecia areata［J］. Drugs, 2020,80（7）:635⁃646. doi: 10.1007/s40265⁃020⁃01293⁃0.
|
| ［18］ |
Ismail FF, Sinclair R. JAK inhibition in the treatment of alopecia areata ⁃ a promising new dawn?［J］. Expert Rev Clin Pharmacol, 2020,13（1）:43⁃51. doi: 10.1080/17512433.2020.1702878.
|
| ［19］ |
Xie WR, Yang XY, Xia HH, et al. Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: a case report and review of the literature［J］. World J Clin Cases, 2019,7（19）:3074⁃3081. doi: 10.12998/wjcc.v7.i19. 3074.
|
